BCSFBain Capital Specialty Finance, Inc.Financial Services · Asset Managementas of 2026-09-16
Horizon

Issued 2026-09-16 at $11.08 · now $11.08 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, BCSF has typically landed between $10.14 and $12.02 — a range of −8.5% to +8.5% from the issuance price $11.08.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

1,946 overlapping 1 month windows · 2018-11-152026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($11.08) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where BCSF has typically landed a month from the 2026-09-16 close of $11.08 — the range is history, not a prediction.

$10.14worst · -8.5%$12.02best · +8.5%
  • now $11.08 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $11.2 (+1.1%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $10.85$11.55
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $10.14$12.02
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,946 windows spanning 2018-11-15 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2020-02-21−61.4%−61.4%+0.0%
2020-03-05−60.5%−60.5%+0.0%
2020-03-06−59.8%−59.8%+0.0%
3 best
2020-10-28+33.9%+0.0%+34.1%
2020-04-06+33.4%+0.0%+47.8%
2020-10-30+33.2%+0.0%+33.2%

1,946 overlapping windows · 2018-11-152026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~8 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
88%
+4.7%
n=8
Feb
50%
+1.3%
n=8
Mar
38%
−7.0%
n=8
Apr
63%
+3.5%
n=8
May
50%
−0.1%
n=8
Jun
38%
+1.1%
n=8
Jul
38%
+0.5%
n=8
Aug
88%
+2.9%
n=8
Sep
25%
−3.7%
n=8
Oct
43%
−0.3%
n=7
Nov
71%
+6.0%
n=7
Dec
75%
+0.4%
n=8

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$14$112026-03-03: 1 insider purchase, $29K — Rusnak-Carlson Sabrina2026-03: 1 open-market purchase, $29K↑ buys↓ salesofficer Rusnak-Carlson Sabrina — Purchase on 2026-03-03, filed same day
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-03-03Rusnak-Carlson SabrinaofficerPurchase2,300 @ $12.55$29K+31.7% of holding+4.9%−11.1%9,560Form 4 · filed same day
2025-03-17Richer Clare StackdirectorPurchase1,530 @ $16.43$25K+7.9% of holding−6.3%−23.5%20,835Form 4 · filed same day

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.